The treatment of GBM neurosphere cultures with γ-secretase inhibitors to prevent Notch cleavage reduces the number of CD133+ cells and in vitro clonogenicity, demonstrating that the Notch pathway is important for stemness maintenance. The gene discussed is PROM1; the disease is glioblastoma.